Bacterial Deoxyribonucleic Acid (DNA)

Bacterial Deoxyribonucleic Acid (DNA) is the fundamental molecule carrying the genetic instructions for the development, functioning, and reproduction of bacteria. In the context of nitroimidazole pharmacology, bacterial DNA serves as the primary therapeutic target for drugs like metronidazole (StatPearls, 2023). Metronidazole acts as a prodrug that is selectively taken up by anaerobic bacteria and protozoa, where it is reduced by the enzyme pyruvate:ferredoxin oxidoreductase (PFOR) or other nitroreductases to form highly reactive nitroso free radicals (PubChem, 2024). These reactive intermediates interact directly with the DNA molecule, causing the loss of its helical structure and inducing strand breakage (PubMed, PMC1074380). This disruption effectively inhibits DNA synthesis and leads to rapid cell death, providing a potent bactericidal effect against anaerobic pathogens. Because the reductive activation occurs primarily in low-oxygen environments, the drug exhibits high selectivity for anaerobes while sparing aerobic host cells (Wikipedia, 2024).

Other names

Bacterial DNAProkaryotic DNAMicrobial DNABacterial genome

Metronidazole is reduced by electron transport proteins (like ferredoxin) in anaerobic bacteria to form reactive nitro radicals. These radicals cause oxidative damage to bacterial DNA, leading to strand breakage, loss of helical structure, and inhibition of nucleic acid synthesis, ultimately resulting in cell death.